{
  "ticker": "EW",
  "last_updated": "2025-05-15T08:34:41.512751",
  "retention_years": 3,
  "count": 23,
  "transactions": [
    {
      "id": 208,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2025-05-11",
      "transaction_shares": "2860.0000",
      "transaction_price": "73.6800",
      "transaction_type": "F",
      "shares_after_transaction": "89562.5511"
    },
    {
      "id": 212,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2025-05-11",
      "transaction_shares": "580.0000",
      "transaction_price": "73.6800",
      "transaction_type": "F",
      "shares_after_transaction": "34996.0000"
    },
    {
      "id": 213,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2025-05-11",
      "transaction_shares": "1200.0000",
      "transaction_price": "73.6800",
      "transaction_type": "F",
      "shares_after_transaction": "39898.0000"
    },
    {
      "id": 215,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2025-05-11",
      "transaction_shares": "988.0000",
      "transaction_price": "73.6800",
      "transaction_type": "F",
      "shares_after_transaction": "206900.3913"
    },
    {
      "id": 217,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2025-05-11",
      "transaction_shares": "816.0000",
      "transaction_price": "73.6800",
      "transaction_type": "F",
      "shares_after_transaction": "52926.3707"
    },
    {
      "id": 223,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2025-05-11",
      "transaction_shares": "271.0000",
      "transaction_price": "73.6800",
      "transaction_type": "F",
      "shares_after_transaction": "26345.1066"
    },
    {
      "id": 203,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2025-05-09",
      "transaction_shares": "3528.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3528.0000"
    },
    {
      "id": 205,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2025-05-09",
      "transaction_shares": "3528.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "33563.0000"
    },
    {
      "id": 207,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2025-05-09",
      "transaction_shares": "5564.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "79296.0000"
    },
    {
      "id": 209,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2025-05-09",
      "transaction_shares": "3528.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "14301.0000"
    },
    {
      "id": 211,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2025-05-09",
      "transaction_shares": "3528.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "11686.0000"
    },
    {
      "id": 220,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Feinberg David T",
      "reporting_owner_cik": "0001486426",
      "reporting_owner_position": null,
      "transaction_date": "2025-05-09",
      "transaction_shares": "3528.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "5836.0000"
    },
    {
      "id": 221,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2025-05-09",
      "transaction_shares": "3528.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "63900.0000"
    },
    {
      "id": 222,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Davis Leslie C.",
      "reporting_owner_cik": "0002021765",
      "reporting_owner_position": null,
      "transaction_date": "2025-05-09",
      "transaction_shares": "3528.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "6583.0000"
    },
    {
      "id": 201,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Bruls Annette",
      "reporting_owner_cik": "0002032351",
      "reporting_owner_position": "CVP, EMEACLA",
      "transaction_date": "2025-05-08",
      "transaction_shares": "6200.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "14280.0000"
    },
    {
      "id": 204,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Dahl Andrew M.",
      "reporting_owner_cik": "0002022347",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2025-05-08",
      "transaction_shares": "3335.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "8106.5266"
    },
    {
      "id": 206,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2025-05-08",
      "transaction_shares": "4225.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "26616.1066"
    },
    {
      "id": 202,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2025-05-07",
      "transaction_shares": "627.0000",
      "transaction_price": "74.9200",
      "transaction_type": "F",
      "shares_after_transaction": "26376.0000"
    },
    {
      "id": 210,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2025-05-07",
      "transaction_shares": "268.0000",
      "transaction_price": "75.0778",
      "transaction_type": "S",
      "shares_after_transaction": "9299.1916"
    },
    {
      "id": 214,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2025-05-07",
      "transaction_shares": "819.0000",
      "transaction_price": "74.9200",
      "transaction_type": "F",
      "shares_after_transaction": "196838.3913"
    },
    {
      "id": 216,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2025-05-07",
      "transaction_shares": "1406.0000",
      "transaction_price": "74.9200",
      "transaction_type": "F",
      "shares_after_transaction": "27698.0000"
    },
    {
      "id": 218,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2025-05-07",
      "transaction_shares": "4253.0000",
      "transaction_price": "74.9200",
      "transaction_type": "F",
      "shares_after_transaction": "52994.5511"
    },
    {
      "id": 219,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2025-05-07",
      "transaction_shares": "851.0000",
      "transaction_price": "74.9200",
      "transaction_type": "F",
      "shares_after_transaction": "45367.3707"
    }
  ]
}